Cite
HARVARD Citation
Zalcman, G. et al. (2016). Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet. 387 (10026), pp. 1405-1414. [Online].